Effect of Pycnogenol ® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial

DiscussionThis trial takes into account comorbid behavioural and physical symptoms, as well as a broad range of innovative immune and oxidative biomarkers, expected to provide fundamental knowledge on ADHD aetiology and therapy. Research on microbiota in ADHD is novel. Moreover, the active control arm is rather unseen in research on nutritional supplements, but of great importance, as patients and parents are often concerned with the side effects of MPH.Trial registrationClinicaltrials.gov number:NCT02700685. Registered on 18 January 2016. EudraCT2016-000215-32. Registered on 4 October 2016.
Source: Trials - Category: Research Source Type: clinical trials